Aust J Gen Pract
The assessment and management of gamma hydroxybutyrate use in general practice.
Phan V, Arunogiri S, Lubman DI
Gamma hydroxybutyrate (GHB) is an illicit drug commonly used in music festival, party and 'chemsex' settings. Most people who use GHB do so occasional ...
Read More
Source: PubMed
Ther Innov Regul Sci
How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?
Tutone M, Villa F, Addis A, Trotta F, Tafuri G
Given the extensive development of new molecules over the last 10 years, regulatory authorities (RAs) have been intensively working on evaluating how ...
Read More
Source: PubMed
Ther Innov Regul Sci
Investigation of Approval Trends and Benefits of New Fixed-Dose Combination Drugs in Japan.
Kikuchi C, Ohno M, Izumo T, Takahashi S, Aoki M, Shimomura H, Kawano Y, Shimada S, Aoyama T
New fixed-dose combination drugs (FDCs) had been developed in limited numbers in Japan. Since regulatory requirements were relaxed in 2005, 73 new FDC ...
Read More
Source: PubMed
Ther Innov Regul Sci
Standardization Consensus of a Hospital Drug Database: An Efficient Tool.
Gayoso-Rey M, Romero-Ventosa EY, Leboreiro-Enríquez B, Álvarez-Sánchez MJ, Gonzalo LB, García-Comesaña J, Piñeiro-Corrales G
Although the electronic prescribing software is the same for all hospitals of a regional health service, each has its own drug database, which it is r ...
Read More
Source: PubMed
Ther Innov Regul Sci
An Overview of the Drug Registration Requirements for Export to Tanzania, Nepal, and Cambodia.
Shelke TV, Khante S, Sarda MB, Mahadik KR, Gaikwad VL
In the semiregulated market, different countries have varying requirements of registration for export to such a specific country or region. The object ...
Read More
Source: PubMed
